Furanocoumarin compounds isolated from Dorstenia foetida potentiate irinotecan anticancer activity against colorectal cancer cells

1D. Hanahan and R. A. Weinberg, Hallmarks of cancer: The next generation, Cell 144(5) 646–674; https://doi.org/10.1016/j.cell.2011.02.013Search in Google Scholar

2R. L. Siegel, K. D. Miller and A. Jemal, Cancer statistics, 2016, CA Cancer J. Clin. 66(1) (2016) 7–30; https://doi.org/10.3322/caac.21332Search in Google Scholar

3M. Vanneman and G. Dranoff, Combining immunotherapy and targeted therapies in cancer treatment, Nat. Rev. Cancer 12(4) (2012) 237–251; https://doi.org/10.1038/nrc3237Search in Google Scholar

4A. Pathak, S. Tanwar, V. Kumar and B. D. Banarjee, Present and future prospect of small molecule & related targeted therapy against human cancer, Vivechan Int. J. Res. 9(1) (2018) 36–49.Search in Google Scholar

5F. A. Fisusi and E. O. Akala, Drug combinations in breast cancer therapy, Pharm. Nanotechnol. 7(1) (2019) 3–23; https://doi.org/10.2174/2211738507666190122111224Search in Google Scholar

6B. B. Mishra and V. K. Tiwari, Natural products: an evolving role in future drug discovery, Eur. J. Med. Chem. 46(10) (2011) 4769–4807; https://doi.org/10.1016/j.ejmech.2011.07.057Search in Google Scholar

7G. M. Cragg and D. J. Newman, Plants as a source of anti-cancer agents, J. Ethnopharmacol. 100(1–2) (2005) 72–79; https://doi.org/10.1016/j.jep.2005.05.011Search in Google Scholar

8F. M. de Man, A. K. L. Goey, R. H. N. van Schaik, R. H. J. Mathijssen and S. Bins, Individualization of irinotecan treatment: A review of pharmacokinetics, pharmacodynamics, and pharmacogenetics, Clin. Pharmacokinet. 57(10) (2018) 1229–1254; https://doi.org/10.1007/s40262-018-0644-7Search in Google Scholar

9A. B. Benson, A. P. Venook, M. M. Al-Hawary, M. A. Arain, Yi-J. Chen, K. K. Ciombor, S. Cohen, H. S. Cooper, D. Deming, L. Farkas, I. Garrido-Laguna, J. L. Grem, A. Gunn, J. R. Hecht, S. Hoffe, J. Hubbard, S. Hunt, K. L. Johung, N. Kirilcuk, S. Krishnamurthi, W. A. Messersmith, J. Meyerhardt, E. D. Miller, M. F. Mulcahy, S. Nurkin, M. J. Overman, A. Parikh, H. Patel, K. Pedersen, L. Saltz, C. Schneider, D. Shibata, J. M. Skibber, C. T. Sofocleous, E. M. Stoffel, E. Stotsky-Himelfarb, C. G. Willett, K. M. Gregory and L. A. Gurski, Colon cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, J. Nat. Compreh. Cancer Network 19(3) (2021) 329–359; https://doi.org/10.6004/jnccn.2021.0012Search in Google Scholar

10A. J. Alonso-Castro, M. L. Villarreal, L. A. Salazar-Olivo, M. Gomez-Sanchez, F. Dominguez and A. Garcia-Carranca, Mexican medicinal plants used for cancer treatment: pharmacological, phyto-chemical and ethnobotanical studies, J. Ethnopharmacol. 133(3) (2011) 945–972; https://doi.org/10.1016/j.jep.2010.11.055Search in Google Scholar

11N. F. Bussa and A. Belayneh, Traditional medicinal plants used to treat cancer, tumors and inflammatory ailments in Harari Region, Eastern Ethiopia, South Afr. J. Bot. 122 (2019) 360–368; https://doi.org/https://doi.org/10.1016/j.sajb.2019.03.025Search in Google Scholar

12T. Teklehaymanot and M. Giday, Ethnobotanical study of medicinal plants used by people in Zegie Peninsula, Northwestern Ethiopia, J. Ethnobiol. Ethnomed. 3 (2007) Article ID 12 (11 pages); https://doi.org/10.1186/1746-4269-3-12Search in Google Scholar

13T. Teklehaymanot, Ethnobotanical study of knowledge and medicinal plants used by the people in Dek Island in Ethiopia, J. Ethnopharmacol. 124(1) (2009) 69–78; https://doi.org/10.1016/j.jep.2009.04.005Search in Google Scholar

14V. Kuete, B. Krusche, M. Youns, I. Voukeng, A. G. Fankam, S. Tankeo, S. Lacmata and T. Efferth, Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts, J. Ethnopharmacol. 134(3) (2011) 803–812; https://doi.org/10.1016/j.jep.2011.01.035Search in Google Scholar

15F. A. Adem, V. Kuete, A. T. Mbaveng, M. Heydenreich, A. Ndakala, B. Irungu, T. Efferth and A. Yenesew, Cytotoxic benzylbenzofuran derivatives from Dorstenia kameruniana, Fitoterapia 128 (2018) 26–30; https://doi.org/10.1016/j.fitote.2018.04.019Search in Google Scholar

16T. Uchiyama, S. Hara, M. Makino and Y. Fujimoto, seco-Adianane-type triterpenoids from Dorstenia brasiliensis (Moraceae), Phytochemistry 60(8) (2002) 761–764.Search in Google Scholar

17V. Kuete, A. T. Mbaveng, M. Zeino, B. Ngameni, G. D. Kapche, S. F. Kouam, B. T. Ngadjui and T. Efferth, Cytotoxicity of two naturally occurring flavonoids (dorsmanin F and poinsettifolin B) towards multi-factorial drug-resistant cancer cells, Phytomedicine 22(7–8) (2015) 737–743; https://doi.org/10.1016/j.phymed.2015.04.007Search in Google Scholar

18R. Heinke, K. Franke, A. Porzel, L. A. Wessjohann, N. A. Ali and J. Schmidt, Furanocoumarins from Dorstenia foetida, Phytochemistry 72(9) (2011) 929–934; https://doi.org/10.1016/j.phytochem.2011.03.008Search in Google Scholar

19C. A. Schneider, W. S. Rasband and K. W. Eliceiri, NIH Image to ImageJ: 25 years of image analysis, Nature Meth. 9(7) (2012) 671–675; https://doi.org/10.1038/nmeth.2089Search in Google Scholar

20P. Kumar, A. Nagarajan and P. D. Uchil, Analysis of cell viability by the MTT assay, Cold Spring Harbor Protoc. 2018(6) (2018) 469–471; https://doi.org/10.1101/pdb.prot095505Search in Google Scholar

21S. W. Jarantow, E. D. Pisors and M. L. Chiu, Introduction to the use of linear and nonlinear regression analysis in quantitative biological assays, Curr. Prot. 3(6) (2023) e801; https://doi.org/https://doi.org/10.1002/cpz1.801Search in Google Scholar

22I. V. Bijnsdorp, E. Giovannetti and G. J. Peters, Analysis of drug interactions, Meth. Mol. Biol. 731 (2011) 421–434; https://doi.org/10.1007/978-1-61779-080-5_34Search in Google Scholar

23T. C. Chou, Drug combination studies and their synergy quantification using the Chou-Talalay method, Cancer Res. 70(2) (2010) 440–446; https://doi.org/10.1158/0008-5472.Can-09-1947Search in Google Scholar

24K. Franke, A. Porzel, M. Masaoud, G. Adam and J. Schmidt, Furanocoumarins from Dorstenia gigas, Phytochemistry 56(6) (2001) 611–621; https://doi.org/10.1016/s0031-9422(00)00419-2Search in Google Scholar

25B. Ngameni, V. Kuete, I. K. Simo, A. T. Mbaveng, P. K. Awoussong, R. Patnam, R. Roy and B. T. Ngadjui, Antibacterial and antifungal activities of the crude extract and compounds from Dorstenia turbinata (Moraceae), South Afr. J. Bot. 75(2) (2009) 256–261; https://doi.org/https://doi.org/10.1016/j.sajb.2008.11.006Search in Google Scholar

26J. Jamalis, F. S. M. Yusof, S. Chander, R. A. Wahab, P. B. D, M. Sankaranarayanan, F. Almalki and T. B. Hadda, Psoralen derivatives: Recent advances of synthetic strategy and pharmacological properties, Antiinflamm. Antiallergy Agents Med. Chem. 19(3) (2020) 222–239; https://doi.org/10.2174/1871523018666190625170802Search in Google Scholar

27Y. Ren, X. Song, Lu Tan, C. Guo, M. Wang, H. Liu, Z. Cao, Y. Li and C. Peng, A review of the pharmacological properties of psoralen, Front. Pharmacol. 11 (2020) Article ID 571535 (18 pages); https://doi.org/10.3389/fphar.2020.571535Search in Google Scholar

28J. Guinney, R. Dienstmann, X. Wang, A. de Reyniès, A. Schlicker, C. Soneson, L. Marisa, P. Roepman, G. Nyamundanda, P. Angelino, B. M. Bot, J. S. Morris, I. M. Simon, S. Gerster, E. Fessler, F. De Sousa E. Melo, E. Missiaglia, H. Ramay, D. Barras, K. Homicsko, D. Maru, G. C. Manyam, B. Broom, V. Boige, B. Perez-Villamil, T. Laderas, R. Salazar, J. W. Gray, D. Hanahan, J. Tabernero, R. Bernards, S. H. Friend, P. Laurent-Puig, J. P. Medema, A. Sadanandam, L. Wessels, M. Delorenzi, S. Kopetz, L. Vermeulen and S. Tejpar, The consensus molecular subtypes of colorectal cancer, Nature Med. 21(11) (2015) 1350–1356; https://doi.org/10.1038/nm.3967Search in Google Scholar

29R. Dienstmann, L. Vermeulen, J. Guinney, S. Kopetz, S. Tejpar and J. Tabernero, Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer, Nat. Rev. Cancer 17(2) (2017) 79–92; https://doi.org/10.1038/nrc.2016.126Search in Google Scholar

30K. C. G. Berg, P. W. Eide, I. A. Eilertsen, B. Johannessen, J. Bruun, S. A. Danielsen, M. Bjørnslett, L. A. Meza-Zepeda, M. Eknæs, G. E. Lind, O. Myklebost, R. I. Skotheim, A. Sveen and R. A. Lothe, Multi-omics of 34 colorectal cancer cell lines – a resource for biomedical studies, Mol. Cancer 16(1) (2017) Article ID 116 (16 pages); https://doi.org/10.1186/s12943-017-0691-ySearch in Google Scholar

31A. Sveen, J. Bruun, P. W. Eide, I. A. Eilertsen, L. Ramirez, A. Murumagi, M. Arjama, S. A. Danielsen, K. Kryeziu, E. Elez, J. Tabernero, J. Guinney, H. G. Palmer, A. Nesbakken, O. Kallioniemi, R. Dienstmann and R. A. Lothe, Colorectal cancer consensus molecular subtypes translated to preclinical models uncover potentially targetable cancer cell dependencies, Clin. Cancer Res. 24(4) (2018) 794–806; https://doi.org/10.1158/1078-0432.ccr-17-1234Search in Google Scholar

32A. Okita, S. Takahashi, K. Ouchi, M. Inoue, M. Watanabe, M. Endo, H. Honda, Y. Yamada and C. Ishioka, Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer, Oncotarget 9(27) (2018) 18698–18711; https://doi.org/10.18632/oncotarget.24617Search in Google Scholar